The Prognostic and Predictive Value of Body Mass Index in Patients with HR+/HER2- Breast Cancer Treated with CDK4/6 Inhibitors: A Systematic Literature Review.
- DOI
- 10.3390/cancers18010081
- Published
- 2025 Dec 26
- Container
- Cancers
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/cancers18010081,
title = {The Prognostic and Predictive Value of Body Mass Index in Patients with HR+/HER2- Breast Cancer Treated with CDK4/6 Inhibitors: A Systematic Literature Review.},
author = {Badau LM and Oprean CM and Ciocoiu AD and Epure P and Vlaicu B},
year = {2025},
journal = {Cancers},
doi = {10.3390/cancers18010081},
url = {https://doi.org/10.3390/cancers18010081}
}RIS
TY - JOUR TI - The Prognostic and Predictive Value of Body Mass Index in Patients with HR+/HER2- Breast Cancer Treated with CDK4/6 Inhibitors: A Systematic Literature Review. AU - Badau LM AU - Oprean CM AU - Ciocoiu AD AU - Epure P AU - Vlaicu B PY - 2025 JO - Cancers DO - 10.3390/cancers18010081 UR - https://doi.org/10.3390/cancers18010081 ER -
APA
LM, B., CM, O., AD, C., P, E., & B, V. (2025). The Prognostic and Predictive Value of Body Mass Index in Patients with HR+/HER2- Breast Cancer Treated with CDK4/6 Inhibitors: A Systematic Literature Review.. Cancers. https://doi.org/10.3390/cancers18010081
Source records
- pubmed · retrieved 2026-09-25T09:12:48.988Z